This article is from the source 'nytimes' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.nytimes.com/2020/04/30/technology/coronavirus-treatment-benevolentai-baricitinib.html
The article has changed 16 times. There is an RSS feed of changes available.
Version 9 | Version 10 |
---|---|
How A.I. Steered Doctors Toward a Possible Coronavirus Treatment | How A.I. Steered Doctors Toward a Possible Coronavirus Treatment |
(7 days later) | |
In late January, researchers at BenevolentAI, an artificial intelligence start-up in central London, turned their attention to the coronavirus. | In late January, researchers at BenevolentAI, an artificial intelligence start-up in central London, turned their attention to the coronavirus. |
Within two days, using technologies that can scour scientific literature related to the virus, they pinpointed a possible treatment with speed that surprised both the company that makes the drug and many doctors who had spent years exploring its effect on other viruses. | Within two days, using technologies that can scour scientific literature related to the virus, they pinpointed a possible treatment with speed that surprised both the company that makes the drug and many doctors who had spent years exploring its effect on other viruses. |
Called baricitinib, the drug was designed to treat rheumatoid arthritis. Though many questions hang over its potential use as a coronavirus treatment, it will soon be tested in an accelerated clinical trial with the National Institutes of Health. It is also being studied in Canada, Italy and other countries. | Called baricitinib, the drug was designed to treat rheumatoid arthritis. Though many questions hang over its potential use as a coronavirus treatment, it will soon be tested in an accelerated clinical trial with the National Institutes of Health. It is also being studied in Canada, Italy and other countries. |
The specialists at BenevolentAI are among many A.I. researchers and data scientists around the world who have turned their attention to the coronavirus, hoping they can accelerate efforts to understand how it is spreading, treat people who have it and find a vaccine. | The specialists at BenevolentAI are among many A.I. researchers and data scientists around the world who have turned their attention to the coronavirus, hoping they can accelerate efforts to understand how it is spreading, treat people who have it and find a vaccine. |
Before the pandemic, the A.I. researchers were part of one of the most hyped and well-funded sectors of the tech industry, pursuing visions of autonomous vehicles and machines that can learn by themselves. Now, they are simply trying to be helpful — working on technology that augments human experts instead of replacing them. | Before the pandemic, the A.I. researchers were part of one of the most hyped and well-funded sectors of the tech industry, pursuing visions of autonomous vehicles and machines that can learn by themselves. Now, they are simply trying to be helpful — working on technology that augments human experts instead of replacing them. |
Medical researchers had spent years exploring baricitinib and similar medications as a way to treat viruses. Baricitinib, a pill taken once a day, can help fight extreme and unwanted activity from the body’s immune system, which occurs with both rheumatoid arthritis and viruses like H.I.V. and can damage healthy cells and tissues. | Medical researchers had spent years exploring baricitinib and similar medications as a way to treat viruses. Baricitinib, a pill taken once a day, can help fight extreme and unwanted activity from the body’s immune system, which occurs with both rheumatoid arthritis and viruses like H.I.V. and can damage healthy cells and tissues. |
In late January, after talking with one of the company’s investors in Asia about the pandemic, Baroness Joanna Shields, the chief executive of BenevolentAI, asked Peter Richardson, BenevolentAI’s vice president of pharmacology, if the company could explore potential treatments. | In late January, after talking with one of the company’s investors in Asia about the pandemic, Baroness Joanna Shields, the chief executive of BenevolentAI, asked Peter Richardson, BenevolentAI’s vice president of pharmacology, if the company could explore potential treatments. |
BenevolentAI quickly joined a race to identify drugs that can block the virus from entering the body’s cells. Researchers at the University of California, San Francisco, and many others labs are looking into similar treatments. | BenevolentAI quickly joined a race to identify drugs that can block the virus from entering the body’s cells. Researchers at the University of California, San Francisco, and many others labs are looking into similar treatments. |
BenevolentAI, which has received more than $292 million from the Singapore sovereign wealth fund Temasek, Goldman Sachs and others, had spent the past several years building technology that could help find information buried in vast troves of academic papers and other scientific literature. | BenevolentAI, which has received more than $292 million from the Singapore sovereign wealth fund Temasek, Goldman Sachs and others, had spent the past several years building technology that could help find information buried in vast troves of academic papers and other scientific literature. |
The technology was designed for the development of new drugs — not for identifying new uses for existing medications — and it had never been used with material related to viruses. | The technology was designed for the development of new drugs — not for identifying new uses for existing medications — and it had never been used with material related to viruses. |
Over two days, a small team used the company’s tools to plumb millions of scientific documents in search of information related to the virus. The tools relied on one of the newest developments in artificial intelligence — “universal language models” that can teach themselves to understand written and spoken language by analyzing thousands of old books, Wikipedia articles and other digital text. | Over two days, a small team used the company’s tools to plumb millions of scientific documents in search of information related to the virus. The tools relied on one of the newest developments in artificial intelligence — “universal language models” that can teach themselves to understand written and spoken language by analyzing thousands of old books, Wikipedia articles and other digital text. |
These A.I. systems are rapidly improving everything from the Google Search engine to automated “chatbots” designed to carry on a conversation. They can also help machines comb through scientific literature, identify particular pieces of information, organize it and retrieve it on command. | These A.I. systems are rapidly improving everything from the Google Search engine to automated “chatbots” designed to carry on a conversation. They can also help machines comb through scientific literature, identify particular pieces of information, organize it and retrieve it on command. |
Using its automated language tools, the company’s engineers generated a detailed and intricately interconnected database of particular biological processes related to the coronavirus. Then Dr. Richardson, who is 65 and a trained pharmacologist, used additional tools to browse through what the technology had found and understand what it meant. | Using its automated language tools, the company’s engineers generated a detailed and intricately interconnected database of particular biological processes related to the coronavirus. Then Dr. Richardson, who is 65 and a trained pharmacologist, used additional tools to browse through what the technology had found and understand what it meant. |
“It is not like we have this giant button and we just smack it and stuff comes out the other end,” said Olly Oechsle, 37, the software engineer who oversees the design of these tools. “Peter has been working in this area since before I was born.” | “It is not like we have this giant button and we just smack it and stuff comes out the other end,” said Olly Oechsle, 37, the software engineer who oversees the design of these tools. “Peter has been working in this area since before I was born.” |
Drawing on what the technology found in the literature, Dr. Richardson could map out the connections between particular human genes and the biological processes affected by the coronavirus. As a multicolored map appeared on his computer screen, two genes leapt out at him. | Drawing on what the technology found in the literature, Dr. Richardson could map out the connections between particular human genes and the biological processes affected by the coronavirus. As a multicolored map appeared on his computer screen, two genes leapt out at him. |
“They stood up and said: ‘Look, we’re here,’” Dr. Richardson said. | “They stood up and said: ‘Look, we’re here,’” Dr. Richardson said. |
Once the genes were identified, he and his colleagues could pinpoint the way that existing medications targeted the genes, visualizing the process through a kind of digital flow chart. They identified baricitinib, made by the American pharmaceutical giant Eli Lilly. | Once the genes were identified, he and his colleagues could pinpoint the way that existing medications targeted the genes, visualizing the process through a kind of digital flow chart. They identified baricitinib, made by the American pharmaceutical giant Eli Lilly. |
Many scientists were already considering similar anti-inflammatory drugs that could reduce a cytokine storm, an extreme response from the body’s immune system that can kill coronavirus patients. | Many scientists were already considering similar anti-inflammatory drugs that could reduce a cytokine storm, an extreme response from the body’s immune system that can kill coronavirus patients. |
But the BenevolentAI researchers went further. Through their software, they found that baricitinib might also prevent the viral infection itself, blocking the way it enters cells. The company said it had no expectations for making money from the research and had no prior relationship with Eli Lilly. | But the BenevolentAI researchers went further. Through their software, they found that baricitinib might also prevent the viral infection itself, blocking the way it enters cells. The company said it had no expectations for making money from the research and had no prior relationship with Eli Lilly. |
Updated June 22, 2020 | |
A commentary published this month on the website of the British Journal of Sports Medicine points out that covering your face during exercise “comes with issues of potential breathing restriction and discomfort” and requires “balancing benefits versus possible adverse events.” Masks do alter exercise, says Cedric X. Bryant, the president and chief science officer of the American Council on Exercise, a nonprofit organization that funds exercise research and certifies fitness professionals. “In my personal experience,” he says, “heart rates are higher at the same relative intensity when you wear a mask.” Some people also could experience lightheadedness during familiar workouts while masked, says Len Kravitz, a professor of exercise science at the University of New Mexico. | |
The steroid, dexamethasone, is the first treatment shown to reduce mortality in severely ill patients, according to scientists in Britain. The drug appears to reduce inflammation caused by the immune system, protecting the tissues. In the study, dexamethasone reduced deaths of patients on ventilators by one-third, and deaths of patients on oxygen by one-fifth. | The steroid, dexamethasone, is the first treatment shown to reduce mortality in severely ill patients, according to scientists in Britain. The drug appears to reduce inflammation caused by the immune system, protecting the tissues. In the study, dexamethasone reduced deaths of patients on ventilators by one-third, and deaths of patients on oxygen by one-fifth. |
The coronavirus emergency relief package gives many American workers paid leave if they need to take time off because of the virus. It gives qualified workers two weeks of paid sick leave if they are ill, quarantined or seeking diagnosis or preventive care for coronavirus, or if they are caring for sick family members. It gives 12 weeks of paid leave to people caring for children whose schools are closed or whose child care provider is unavailable because of the coronavirus. It is the first time the United States has had widespread federally mandated paid leave, and includes people who don’t typically get such benefits, like part-time and gig economy workers. But the measure excludes at least half of private-sector workers, including those at the country’s largest employers, and gives small employers significant leeway to deny leave. | The coronavirus emergency relief package gives many American workers paid leave if they need to take time off because of the virus. It gives qualified workers two weeks of paid sick leave if they are ill, quarantined or seeking diagnosis or preventive care for coronavirus, or if they are caring for sick family members. It gives 12 weeks of paid leave to people caring for children whose schools are closed or whose child care provider is unavailable because of the coronavirus. It is the first time the United States has had widespread federally mandated paid leave, and includes people who don’t typically get such benefits, like part-time and gig economy workers. But the measure excludes at least half of private-sector workers, including those at the country’s largest employers, and gives small employers significant leeway to deny leave. |
So far, the evidence seems to show it does. A widely cited paper published in April suggests that people are most infectious about two days before the onset of coronavirus symptoms and estimated that 44 percent of new infections were a result of transmission from people who were not yet showing symptoms. Recently, a top expert at the World Health Organization stated that transmission of the coronavirus by people who did not have symptoms was “very rare,” but she later walked back that statement. | So far, the evidence seems to show it does. A widely cited paper published in April suggests that people are most infectious about two days before the onset of coronavirus symptoms and estimated that 44 percent of new infections were a result of transmission from people who were not yet showing symptoms. Recently, a top expert at the World Health Organization stated that transmission of the coronavirus by people who did not have symptoms was “very rare,” but she later walked back that statement. |
Touching contaminated objects and then infecting ourselves with the germs is not typically how the virus spreads. But it can happen. A number of studies of flu, rhinovirus, coronavirus and other microbes have shown that respiratory illnesses, including the new coronavirus, can spread by touching contaminated surfaces, particularly in places like day care centers, offices and hospitals. But a long chain of events has to happen for the disease to spread that way. The best way to protect yourself from coronavirus — whether it’s surface transmission or close human contact — is still social distancing, washing your hands, not touching your face and wearing masks. | Touching contaminated objects and then infecting ourselves with the germs is not typically how the virus spreads. But it can happen. A number of studies of flu, rhinovirus, coronavirus and other microbes have shown that respiratory illnesses, including the new coronavirus, can spread by touching contaminated surfaces, particularly in places like day care centers, offices and hospitals. But a long chain of events has to happen for the disease to spread that way. The best way to protect yourself from coronavirus — whether it’s surface transmission or close human contact — is still social distancing, washing your hands, not touching your face and wearing masks. |
A study by European scientists is the first to document a strong statistical link between genetic variations and Covid-19, the illness caused by the coronavirus. Having Type A blood was linked to a 50 percent increase in the likelihood that a patient would need to get oxygen or to go on a ventilator, according to the new study. | A study by European scientists is the first to document a strong statistical link between genetic variations and Covid-19, the illness caused by the coronavirus. Having Type A blood was linked to a 50 percent increase in the likelihood that a patient would need to get oxygen or to go on a ventilator, according to the new study. |
The unemployment rate fell to 13.3 percent in May, the Labor Department said on June 5, an unexpected improvement in the nation’s job market as hiring rebounded faster than economists expected. Economists had forecast the unemployment rate to increase to as much as 20 percent, after it hit 14.7 percent in April, which was the highest since the government began keeping official statistics after World War II. But the unemployment rate dipped instead, with employers adding 2.5 million jobs, after more than 20 million jobs were lost in April. | The unemployment rate fell to 13.3 percent in May, the Labor Department said on June 5, an unexpected improvement in the nation’s job market as hiring rebounded faster than economists expected. Economists had forecast the unemployment rate to increase to as much as 20 percent, after it hit 14.7 percent in April, which was the highest since the government began keeping official statistics after World War II. But the unemployment rate dipped instead, with employers adding 2.5 million jobs, after more than 20 million jobs were lost in April. |
States are reopening bit by bit. This means that more public spaces are available for use and more and more businesses are being allowed to open again. The federal government is largely leaving the decision up to states, and some state leaders are leaving the decision up to local authorities. Even if you aren’t being told to stay at home, it’s still a good idea to limit trips outside and your interaction with other people. | States are reopening bit by bit. This means that more public spaces are available for use and more and more businesses are being allowed to open again. The federal government is largely leaving the decision up to states, and some state leaders are leaving the decision up to local authorities. Even if you aren’t being told to stay at home, it’s still a good idea to limit trips outside and your interaction with other people. |
Common symptoms include fever, a dry cough, fatigue and difficulty breathing or shortness of breath. Some of these symptoms overlap with those of the flu, making detection difficult, but runny noses and stuffy sinuses are less common. The C.D.C. has also added chills, muscle pain, sore throat, headache and a new loss of the sense of taste or smell as symptoms to look out for. Most people fall ill five to seven days after exposure, but symptoms may appear in as few as two days or as many as 14 days. | Common symptoms include fever, a dry cough, fatigue and difficulty breathing or shortness of breath. Some of these symptoms overlap with those of the flu, making detection difficult, but runny noses and stuffy sinuses are less common. The C.D.C. has also added chills, muscle pain, sore throat, headache and a new loss of the sense of taste or smell as symptoms to look out for. Most people fall ill five to seven days after exposure, but symptoms may appear in as few as two days or as many as 14 days. |
If air travel is unavoidable, there are some steps you can take to protect yourself. Most important: Wash your hands often, and stop touching your face. If possible, choose a window seat. A study from Emory University found that during flu season, the safest place to sit on a plane is by a window, as people sitting in window seats had less contact with potentially sick people. Disinfect hard surfaces. When you get to your seat and your hands are clean, use disinfecting wipes to clean the hard surfaces at your seat like the head and arm rest, the seatbelt buckle, the remote, screen, seat back pocket and the tray table. If the seat is hard and nonporous or leather or pleather, you can wipe that down, too. (Using wipes on upholstered seats could lead to a wet seat and spreading of germs rather than killing them.) | If air travel is unavoidable, there are some steps you can take to protect yourself. Most important: Wash your hands often, and stop touching your face. If possible, choose a window seat. A study from Emory University found that during flu season, the safest place to sit on a plane is by a window, as people sitting in window seats had less contact with potentially sick people. Disinfect hard surfaces. When you get to your seat and your hands are clean, use disinfecting wipes to clean the hard surfaces at your seat like the head and arm rest, the seatbelt buckle, the remote, screen, seat back pocket and the tray table. If the seat is hard and nonporous or leather or pleather, you can wipe that down, too. (Using wipes on upholstered seats could lead to a wet seat and spreading of germs rather than killing them.) |
If you’ve been exposed to the coronavirus or think you have, and have a fever or symptoms like a cough or difficulty breathing, call a doctor. They should give you advice on whether you should be tested, how to get tested, and how to seek medical treatment without potentially infecting or exposing others. | If you’ve been exposed to the coronavirus or think you have, and have a fever or symptoms like a cough or difficulty breathing, call a doctor. They should give you advice on whether you should be tested, how to get tested, and how to seek medical treatment without potentially infecting or exposing others. |
If you’re sick and you think you’ve been exposed to the new coronavirus, the C.D.C. recommends that you call your healthcare provider and explain your symptoms and fears. They will decide if you need to be tested. Keep in mind that there’s a chance — because of a lack of testing kits or because you’re asymptomatic, for instance — you won’t be able to get tested. | If you’re sick and you think you’ve been exposed to the new coronavirus, the C.D.C. recommends that you call your healthcare provider and explain your symptoms and fears. They will decide if you need to be tested. Keep in mind that there’s a chance — because of a lack of testing kits or because you’re asymptomatic, for instance — you won’t be able to get tested. |
Through Justin Stebbing, a professor of oncology at Imperial College London, the researchers sent their findings to The Lancet, one of Britain’s oldest and most respected medical journals, in early February. Like many other companies and researchers now exploring treatments across the globe, the team wanted to share what it had learned as widely as possible. | Through Justin Stebbing, a professor of oncology at Imperial College London, the researchers sent their findings to The Lancet, one of Britain’s oldest and most respected medical journals, in early February. Like many other companies and researchers now exploring treatments across the globe, the team wanted to share what it had learned as widely as possible. |
The next day, at Emory University Hospital in Atlanta, Dr. Vincent Marconi opened an email from a colleague, Dr. Raymond Schinazi, that pointed him and other colleagues to the paper. They had spent eight years exploring baricitinib and other drugs as a treatment for H.I.V., and they knew such drugs could potentially help coronavirus patients. | The next day, at Emory University Hospital in Atlanta, Dr. Vincent Marconi opened an email from a colleague, Dr. Raymond Schinazi, that pointed him and other colleagues to the paper. They had spent eight years exploring baricitinib and other drugs as a treatment for H.I.V., and they knew such drugs could potentially help coronavirus patients. |
But they had not settled on baricitinib as a viable option, and they had not identified the specific properties that might allow the drug to fight the virus. Nor had the scientists at Eli Lilly. | But they had not settled on baricitinib as a viable option, and they had not identified the specific properties that might allow the drug to fight the virus. Nor had the scientists at Eli Lilly. |
At Emory, the lab researchers were shocked that the paper had come from BenevolentAI. “It was crazy,” said Christina Gavegnano, who took part in the work with H.I.V. “We kept asking: ‘Who are these people? Does anyone know them?’” | At Emory, the lab researchers were shocked that the paper had come from BenevolentAI. “It was crazy,” said Christina Gavegnano, who took part in the work with H.I.V. “We kept asking: ‘Who are these people? Does anyone know them?’” |
A month later, Dr. Marconi proposed a clinical trial with baricitinib and another drug. As coronavirus cases mounted at his hospital, he and his clinicians administered the pill as a compassionate measure to patients, with encouraging results. | A month later, Dr. Marconi proposed a clinical trial with baricitinib and another drug. As coronavirus cases mounted at his hospital, he and his clinicians administered the pill as a compassionate measure to patients, with encouraging results. |
“We normally talk about ‘bench to bedside,’” Dr. Stebbing said, referring to moving quickly from laboratory bench research into the treatment of patients. “This is about ‘computer to bench to bedside.’” | “We normally talk about ‘bench to bedside,’” Dr. Stebbing said, referring to moving quickly from laboratory bench research into the treatment of patients. “This is about ‘computer to bench to bedside.’” |
Unaware of what was happening in Atlanta, Dr. Mario Corbellino administered the drug as a compassionate measure at a hospital in Milan after reviewing the research from BenevolentAI and soon proposed another clinical trial. He and other infectious-disease specialists, he said, feel more comfortable testing this kind of drug if it has the potential to not just reduce an immune system response but prevent the viral infection. | Unaware of what was happening in Atlanta, Dr. Mario Corbellino administered the drug as a compassionate measure at a hospital in Milan after reviewing the research from BenevolentAI and soon proposed another clinical trial. He and other infectious-disease specialists, he said, feel more comfortable testing this kind of drug if it has the potential to not just reduce an immune system response but prevent the viral infection. |
Dr. Dan Skovronsky, chief scientific officer at Eli Lilly, warned that it was still unclear what effect the drug would have on coronavirus patients. Even after the clinical trial, he said, it may not be clear whether the antiviral properties pinpointed by BenevolentAI are as effective as they might seem to be. | Dr. Dan Skovronsky, chief scientific officer at Eli Lilly, warned that it was still unclear what effect the drug would have on coronavirus patients. Even after the clinical trial, he said, it may not be clear whether the antiviral properties pinpointed by BenevolentAI are as effective as they might seem to be. |
He also said those properties were not something his scientists would have discovered so quickly on their own. “There is so much complexity to biology and there is so much information out there, it is hard — if not impossible — for one person to put together the clues that are already there in the literature,” he said. | He also said those properties were not something his scientists would have discovered so quickly on their own. “There is so much complexity to biology and there is so much information out there, it is hard — if not impossible — for one person to put together the clues that are already there in the literature,” he said. |